AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 284: H939-H946, 2003. First published November 14, 2002; doi:10.1152/ajpheart.00610.2002
0363-6135/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/3/H939    most recent
00610.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masuki, S.
Right arrow Articles by Nose, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masuki, S.
Right arrow Articles by Nose, H.
Vol. 284, Issue 3, H939-H946, March 2003

Enhanced baroreflex sensitivity in free-moving calponin knockout mice

Shizue Masuki1, Michiko Takeoka2, Shun'Ichiro Taniguchi2, and Hiroshi Nose1

Departments of 1 Sports Medicine, and 2 Molecular Oncology and Angiology, Research Center on Aging and Adaptation, Shinshu University School of Medicine, Matsumoto 390-8621, Japan


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
APPENDIX
REFERENCES

Calponin is an actin binding protein in vascular smooth muscle that modifies contractile responses. However, its role in mean arterial pressure (MAP) regulation has not been clarified. To assess this, MAP and heart rate (HR) were measured in calponin knockout (KO) mice, and the results were compared with those in wild-type (WT) mice. The measurements were performed every 100 ms during a 60-min free-moving state each day for 3 days. Mice in both groups rested during ~70% of the total measuring period. The mean HR during rest was significantly lower in KO mice than in WT mice but with no significant difference in MAP between the groups. The change in HR response (Delta HR) to spontaneous change in MAP (Delta MAP) varied in a wider range in KO mice with an 80% increase in the coefficient of variation for HR (P < 0.05), whereas MAP in KO mice was controlled in a narrow range similar to that in WT mice. The baroreflex sensitivity (Delta HR/Delta MAP), determined from the change in HR to the spontaneous change in MAP, was twofold higher in KO mice than that in WT mice (P < 0.01), whereas there were no significant differences in the baroreflex sensitivity determined by intravascular administration of phenylephrine and sodium nitroprusside between the two groups (P > 0.1). The MAP response to the administrated doses of phenylephrine in KO mice was reduced to one-half of that in WT mice (P < 0.01) but with no significant difference in the response to sodium nitroprusside between the groups. The differences in HR variability and the spontaneous baroreflex sensitivity between the two groups completely disappeared after carotid sinus denervation. These results suggest that the higher variability in HR for KO mice was caused by the increased spontaneous arterial baroreflex sensitivity, though not detected by the intra-arterial administration of the drug, and that the higher variability of HR may be a compensatory adaptation to the blunted alpha -adrenergic response of peripheral vessels to sympathetic nervous activity.

carotid sinus denervation; heart rate variability


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
APPENDIX
REFERENCES

CALPONIN, also called basic calponin or calponin H1, was first isolated from the chicken gizzard as an actin-binding protein, which was reported to be involved in the regulation of smooth muscle contraction (22). Calponin was reported to reduce unloaded isometric forces and shortening velocity (8, 14, 19, 23) by the inhibition of actomyosin ATPase activity in a reconstituted isolated filament system (26). On the other hand, there have been several studies suggesting that calponin increases the contractile response to norepinephrine (NE) (18) or phenylephrine (PE) (9, 16, 20) by facilitating agonist-induced signal transduction.

With the exception of these in vitro studies, however, there have been few studies investigating the role of calponin in arterial pressure regulation in the whole body. Because arterial pressure is determined from the product of cardiac output and total peripheral resistance, the dysfunction of vascular smooth muscle contraction itself and/or the impaired alpha -adrenergic response to sympathetic nervous activity in genetically calponin-deficient mice [knockout (KO) mice] would make arterial pressure unstable. Alternatively, baroreflex control would compensate for the impaired arterial pressure regulation by changing the heart rate (HR) and/or cardiac output in the group.

To examine these hypotheses, we measured mean arterial pressure (MAP) and HR in the free-moving KO mice and determined the baroreflex sensitivity from the change in heart rate (Delta HR) in response to the spontaneous change in MAP (Delta MAP) and compared the results with those in wild-type (WT) mice. We also determined the baroreflex sensitivity by intravascular administration of alpha -adrenergic agonist of PE or sodium nitroprusside (SNP) and compared the results between the groups. Moreover, we assessed the effects of carotid denervation on MAP to examine the compensatory effects of baroreflexes, if any, in the KO mice.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
APPENDIX
REFERENCES

Animals

The KO mice used in the present study were generated from the same cell line in previous studies (14, 23, 27). Briefly, calponin H1 gene was cloned from a 129SVJ mouse genomic library, and the fragment containing exons 5-7 was replaced with pMC1neopGKgpt. Clones that underwent homologous recombination were injected into C57BL/6J blastocysts. In the present study, we compared MAP regulation between the mice lacking calponin H1 gene (KO mice) and the mice carrying normal calponin H1 gene (WT mice). Absence of calponin H1 expression in the aorta of the KO mice was confirmed by RT-PCR (Fig. 1) and Western blotting with a calponin H1-specific antibody, as reported elsewhere (14, 27). Yoshikawa et al. (27) reported that other isoforms of calponin were not overexpressed in the embryonic cells by RT-PCR in the KO mice from the same cell line as in the present study. Adult male mice aged 10-29 wk (WT, n = 17, 30.3 ± 0.9 g body wt, and KO, n = 16, 31.9 ± 1.3 g body wt) were housed in cages at 25°C with the lights on from 7 AM to 7 PM. Food and water was given ad libitum. The mice were closely monitored to ensure that none experienced undue stress or discomfort.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 1.   RT-PCR analysis of calponin H1 (1,295 bp) and GAPDH (731 bp) using mRNA extracted from an aorta. Compared with the wild-type (WT) mouse, calponin H1 is lacking in the knockout (KO) mouse.

The procedures used here were in accordance with the American Physiological Society's "Guiding Principles for Research Involving Animals and Human Beings" and conducted with permission from the Animal Ethics Committee of Shinshu University School of Medicine.

Surgical Procedures

Intact condition. Details were reported elsewhere (15). Briefly, the arterial catheter was fashioned from a 450-mm segment of polyethylene tube (SP31, ID: 0.5 mm, OD: 0.8 mm, Natsume; Tokyo, Japan) welded to a 22-mm polyethylene tube segment (SP8, ID 0.2 mm, OD 0.5 mm, Natsume) with a tip that was tapered to ~0.3 mm in diameter over hot air. At least 4-6 days before the experiment, the mice were anesthetized with pentobarbital sodium (50 mg/kg body wt ip), and the hair over the anterior left lower limb and between the scapulas was shaved. The skin was sterilized with povidon iodine (Meiji; Tokyo, Japan). The surgery was performed on a warming pad kept at 37°C (model 39, DP Scientific; Braintree, MA). The left femoral artery was exposed, and a small incision was made in the arterial wall with microspring scissors. The tip of the catheter was introduced through the incision and advanced by ~20 mm so that the tip was placed 5 mm below the bifurcation of the left renal artery. The catheter was secured to the leg muscle and tunneled subcutaneously and exteriorized between the scapulas. The exteriorized catheter was connected to a cannula swivel (model TCS2-21, Tsumura; Tokyo, Japan), and the mice were placed in a home cage with a free-moving system (Tsumura). A few hours after the preparation, the mice recovered to move the catheterized limb freely. The catheter was flushed everyday with 500 IU heparin in 0.2 ml of saline. The mice were allowed to recover for 4-6 days after catheter implantation before the measurements were taken.

Carotid denervated condition. At least 3 days after arterial catheter implantation, mice were anesthetized again as described above. A midline incision was made in the anterior neck and the area of the carotid bifurcation was exposed. The internal, external, and common carotid arteries were stripped of connective tissues, and the region was painted with 10% phenol in ethanol, as reported previously in rats (12, 24). The recovery period from the carotid denervation was at least 4 days before the measurements of HR and MAP. The success of the denervation was confirmed by the increased fluctuation in MAP and no HR response to the fluctuation as in Table 1 (4).

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   MAP, HR, and spontaneous baroreflex sensitivity (Delta HR/Delta MAP) in WT and KO mice

Measurements

MAP was measured through the arterial catheter connected to a pressure transducer (model TP-400T, Nihon Kohden; Tokyo, Japan), with an amplifier (DC Strain Amplifier 6M77, NEC; Tokyo, Japan). HR was counted from the arterial pressure pulse with a tachometer (model AT-601G, Nihon Kohden). The response time of the tachometer at a given change in the pressure pulse rate was 100 ms, which was short enough to detect the Delta HR in the present study. MAP was continuously recorded with a digital data recorder (Thermal Arraycorder WR 8500, Graphtec; Yokohama, Japan) at 100-ms intervals through a low-pass filter (recorder frequency 1.5 Hz) to remove pulsatile arterial pressure signals. MAP and HR were measured in their home cages during a 60-min period, randomly chosen between 9 AM and 4 PM, and the measurements on the same mouse were conducted three times on separate days. Figure 2 shows a typical example of HR and MAP measured for 60 min in a free-moving WT mouse. The resting period was distinguished from the moving period according to three criteria: 1) virtually not moving, 2) <10-mmHg increase in MAP, and 3) <90 beats/min increase in HR. The coefficient of variations (CVs) of HR and MAP during rest in each mouse were determined as the values averaged for ~135 min (~45 min × 3 days). The means ± SE for 6 WT and 6 KO mice are presented in Table 1.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 2.   Mean arterial pressure (MAP) and heart rate (HR) during measuring period of 60 min in a WT mouse. The three criteria to judge as resting state were the following: 1) virtually not moving, 2) <10 mmHg increase in MAP, and 3) <90 beats/min increase in HR.

Spontaneous Baroreflex Sensitivity Analyses

HR and MAP during the total resting period for 3 days (~135 min, n = ~81,000) were used to determine baroreflex sensitivity in each mouse at rest. Because spontaneous change in MAP and consecutive change in HR were observed at 5-15 cycles/min (4-12 s/cycle) as shown in Figs. 3 and 4, the relation between Delta MAP and the consecutive Delta HR from the baselines was analyzed every 4 s using a cross-correlation function given in the following formulas (1)
R(t)=f[<IT>&Dgr;x</IT>(<IT>t+&Dgr;t</IT>)<IT>,&Dgr;y</IT>(<IT>t</IT>)]

&Dgr;x(t)=x(t)−<A><AC>x</AC><AC>&cjs1171;</AC></A>(t), &Dgr;y(t)=y(t)−<A><AC>y</AC><AC>&cjs1171;</AC></A>(t)

<A><AC>x</AC><AC>&cjs1171;</AC></A>(t)=<FR><NU>1</NU><DE>&tgr;</DE></FR> <LIM><OP>∫</OP><LL>t</LL><UL>t+&tgr;</UL></LIM>x(t)d<IT>t,</IT> <IT><A><AC>y</AC><AC>&cjs1171;</AC></A></IT>(<IT>t</IT>)<IT> = </IT><FR><NU>1</NU><DE><IT>&tgr;</IT></DE></FR> <LIM><OP>∫</OP><LL><IT>t</IT></LL><UL><IT>t+&tgr;</IT></UL></LIM><IT>y</IT>(<IT>t</IT>)<IT>dt</IT>
where R(t) is a cross-correlation coefficient between x (= MAP) and y (= HR) at the given time of t after correction for the delay time (Delta t = 0.6 s) in response to HR change, f is function, and d is derivative. The x(t) and <A><AC>y</AC><AC>&cjs1171;</AC></A>(t) were averaged values of MAP and HR, respectively, from time t to t + tau  (= 4 s). The detailed numerical analyses are given in the APPENDIX. A regression equation was determined from the pooled data during rest in each mouse. The slope of the regression line was used as an index of the spontaneous baroreflex sensitivity.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 3.   Typical examples of MAP and HR at rest for 16 min in a WT mouse (A) and in a KO mouse (B). The sections of the traces with short bars are shown in detail in Fig. 4.



View larger version (22K):
[in this window]
[in a new window]
 
Fig. 4.   HR and MAP in a WT mouse (A) and a KO mouse (B) from the parts indicated by the solid bars in Fig. 3, A and B, respectively. A rise in MAP caused a fall in HR and inversely a fall in MAP caused a rise in HR after a 0.6-s delay in both groups. The amplitude of the HR response at a given change in MAP was greater in the KO mouse than that in the WT mouse.

Drug-Induced Baroreflex Sensitivity Analyses

The baroreflex sensitivity was also determined from sigmoid the response of HR to MAP altered by intra-arterial administration of SNP or PE. Briefly, after we confirmed that the baselines of MAP and HR were 15 or 30 µg/kg (90 µg/ml saline) of SNP and 5 or 10 µg/kg (30 µg/ml) of PE was injected with a 100-µl syringe (Hamilton; Reno, NV) through a bifurcation of a Y-shaped tube (model CMA/12, BAS; Tokyo, Japan) inserted in a catheter for arterial pressure measurement, which was placed in the femoral artery 4-6 days before the experiment. Because no sufficient increase in MAP was obtained at 10 µg/kg of PE in KO mice, an additional experiment at 50 µg/kg of PE (300 µg/ml) was performed. The responses until ~1 s after the injection were not measured because one bifurcation of the Y-shaped tube connected to the pressure transducer was closed during the drug injections into the other bifurcation. Thereafter, MAP and HR responses were recorded and used for drug-induced baroreflex sensitivity analyses.

The baroreflex curves expressed as the relationship between MAP and HR were analyzed with a logistic sigmoid function according to the following equation (11, 17)
HR<IT>=&agr;/</IT>[1<IT>+e</IT><SUP><IT>&bgr;</IT>(MAP<IT>−&ggr;</IT>)</SUP>]<IT>+&dgr;</IT>
where alpha  is the range between the upper and lower plateau, e is exponential function, beta  is a coefficient to calculate the gain as a function of pressure, gamma  is the MAP at midrange of the curve (midpoint), and delta  is the lower plateau. Each parameter and the threshold pressure (lowest pressure that products a significant decline in HR) and the saturation pressure (pressure necessary to achieve maximal inhibition of HR) were determined by fitting the equation to minimize the sum of y distance between the experimental data (HR) and the y value (HR) obtained by substituting x value (MAP) for the equation.

Statistical Analysis

Values are expressed as means ± SE. The pairwise comparisons in mean and CV values between the KO and WT mice were calculated by using Fisher's least-significant difference test with the post hoc test after confirming the significance with a two-way ANOVA.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
APPENDIX
REFERENCES

Table 1 shows MAP and HR at rest in the WT and KO mice in carotid innervated and denervated conditions. The resting period in both groups was 70-80% of the total measuring period with no significant differences between the groups or between innervated and denervated conditions. In the innervated condition, HR was significantly lower in the KO mice than in the WT mice (P < 0.05), whereas MAP was not significantly different between the groups (P > 0.9). After carotid sinus denervation, MAP increased significantly (P < 0.05) in the WT mice but not in the KO mice (P > 0.4), whereas HR in the KO mice increased significantly (P < 0.001) but not in the WT mice (P > 0.2). In the innervated condition, there were no significant differences in the CV of MAP between the groups, whereas that of HR was twofold higher in the KO mice than that in the WT mice (P < 0.001). After carotid denervation, the CV of MAP increased by twofold in both groups (P < 0.001), whereas the CV of HR in the KO mice decreased to one-half that in the innervated mice (P < 0.001), which was not significantly different from that in the innervated WT mice. There was no significant change in the CV of HR for the WT mice after denervation.

Figure 3 shows typical examples of MAP and HR during the resting period of 16 min in one typical WT mouse (Fig. 3A) and one typical KO mouse (Fig. 3B). Although the variability in MAP was similar between the groups, that in HR was significantly higher in the KO mice than that in the WT mice.

Figure 4, A and B, is enlarged from the parts indicated by closed bars in Fig. 3, A and B, respectively. As shown in Fig. 4, a rise in MAP caused a fall in HR and inversely a fall in MAP caused a rise in HR after a 0.6-s delay.

Figure 5 shows an example of R(t) between HR and MAP at the given time of t in a WT mouse, demonstrating a significantly positive or negative correlation above or below the dotted lines of P < 0.05, respectively. As summarized in Table 1, the negative correlation period between Delta HR and Delta MAP was 69% of the total measuring period in the KO mice, which was significantly >51% in the WT mice (P < 0.01). On the other hand, the significant positive correlation period was 4% in the KO mice, which was significantly <11% in the WT mice (P < 0.05). After carotid sinus denervation, the negative correlation period decreased to 40% of the predenervated level in the WT mice (P < 0.001) and to 20% in the KO mice (P < 0.001), whereas that of the positive correlation increased threefold in the WT mice (P < 0.01) and sixfold in the KO mice (P < 0.01).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 5.   R(t), a cross-correlation function between a change in MAP (Delta MAP) and Delta HR, in a WT mouse, is presented as a function of time. Delta MAP and Delta HR during the period where R(t) was higher than the level of P < 0.05 were adopted for regression analyses to determine spontaneous baroreflex sensitivity (shaded area). A more detailed explanation is given in the text.

The significant negative correlations were pooled for regression analyses and the results are presented in Fig. 6A for the WT mice and in Fig. 6B for the KO mice. As summarized in Table 1, the negative slope of Delta HR/Delta MAP was twofold steeper in the KO mice than that in the WT mice in the innervated condition (P < 0.001). After carotid sinus denervation, the negative slope decreased to one-third that in the innervated condition for the WT mice (P < 0.001) and to one-sixth in the KO mice (P < 0.001), and the significant difference between the groups in the innnervated condition disappeared (P > 0.7). The positive slope was not significantly different between the groups in the innervated condition, but after denervation it decreased to 53% of the predenervated value in the WT mice (P < 0.05) and to 30% in the KO mice (P < 0.001) with no significant difference between the groups (P > 0.9).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 6.   The relation between Delta MAP and Delta HR adopted during the significant negative correlation period in the WT mice (A) and KO mice (B). The data number in each mouse was ~42,000 in the WT mice and ~56,000 in the KO mice.

Figure 7 shows the changes in MAP after the injections of PE and SNP. The increases in MAP by 5 and 10 µg/kg of PE in the KO mice were 9.3 ± 0.4 and 18.2 ± 1.4 mmHg, respectively, which were significantly <23.0 ± 1.5 and 28.8 ± 2.7 mmHg in the WT mice, respectively (P < 0.001). On the other hand, there were no significant differences in vascular response to SNP between the two groups (P > 0.07).


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 7.   Change in MAP after injection of phenylephrine (PE) at 5, 10, and 50 µg/kg and sodium nitroprusside (SNP) at 15 and 30 µg/kg. Means ± SE bars on 5 WT and 5 KO mice. *** P < 0.001, significant differences between the WT and KO mice.

Figure 8A shows a typical example of the relation between MAP and HR after injection of PE and SNP into a WT mouse with a best-fit sigmoid baroreflex curve generated, as described above. Figure 8B shows the best-fit curves to the mean values of the midpoint, threshold, saturation, maximum, and minimum determined in WT and KO mice. There were no significant differences in the parameters between the two groups as summarized in Table 2.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 8.   The relation between MAP and HR after injection of PE and SNP. A: typical example of a WT mouse. A total of 85 measurements are presented. The best-fit sigmoid baroreflex curve generated as described in the text is also presented. B: composite baroreflex curves and baroreflex parameters for WT and KO mice are presented. a, Maximum; b, threshold; c, midpoint; d, saturation; e, minimum. Means ± SE bars refer to 5 WT and 5 KO mice.


                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Parameters of drug-induced baroreflex sensitivity analyses


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
APPENDIX
REFERENCES

In this study, we first chronically implanted catheters in the calponin KO mice and measured MAP and HR under free-moving conditions. The major findings were the following: 1) the variability of HR in the KO mice during rest was twofold higher than that in the WT mice, whereas that in MAP was not significantly different between the two groups; 2) baroreflex sensitivity, determined by the HR response to spontaneous change in MAP, was twofold higher in the KO mice than that in the WT mice; 3) there was no significant difference in the sensitivity determined by intra-arterial administration of the PE or SNP; 4) MAP response to the PE in the KO mice was reduced to one-half that in the WT mice but with no significant difference in the response to SNP; and 5) the higher variability of HR and the higher baroreflex sensitivity in the KO mice disappeared after carotid sinus denervation.

The baroreflex sensitivity was determined from the HR response to spontaneous change in MAP (Table 1) and from induced change in MAP by drug injections (Table 2). Recently, the baroreflex sensitivity was evaluated from the pulse interval response to spontaneous change in arterial pressure in conscious cats (2), humans (6, 7), and anesthetized mice (25). It was determined that the sensitivity from the slope of the pulse intervals and the systolic pressure, based on the findings that changes in three or more consecutive pulse intervals in response to the preceding systolic arterial pressure were positively correlated. In the present study, although we failed to measure precisely the systolic and diastolic pressures because of the damper effect of the measuring system, MAP fluctuated at the frequency of 5-15 cycles/min, followed by an almost similar frequency of fluctuation of HR after a short delay time. When analyzed by a cross-correlation function at 4-s intervals, Delta HR was negatively correlated with Delta MAP during 51% of the total resting period in the WT mice and 69% in the KO mice in the innervated condition. Moreover, after sinus denervation, the percentage period of the negative correlation was markedly diminished in both groups. In addition, the baroreflex sensitivity determined by the spontaneous method in the WT mice agreed well with previously reported findings in mice by the drug-induced method (13) and spontaneous method (25). Thus the baroreflex sensitivity by the spontaneous method in the present study was reliable enough to clarify the difference in the sensitivity between the WT and KO mice.

In the KO mice, MAP was controlled in such a narrow range as in the WT mice, whereas the HR variability was significantly higher than that in the WT mice (Fig. 3 and Table 1), which was adequately explained by the enhanced spontaneous baroreflex sensitivity in the KO mice (Fig. 6B and Table 1). Moreover, in the KO mice, the negative correlation period between Delta HR and Delta MAP was 35% longer than that in the WT mice and the positive correlation period was 50% shorter (Table 1). In addition, all of these differences between the groups disappeared after carotid sinus denervation (Table 1). These results suggest that MAP in the KO mice was more strongly controlled by baroreflexes than that in the WT mice.

The enhanced baroreflex sensitivity in the KO mice may be associated with vascular characteristics due to calponin deficiency in the KO mice. Regarding the molecular aspects of calponin function in the smooth muscle, Winder and Walsh (26) suggested in a reconstituted isolated filament system that calponin inhibits actomyosin ATPase by binding to the actin filament. Takahashi et al. (23) suggested that calponin reduced the shortening velocity in the tonic phase of contraction by regulating of cross-bridge cycling. On the other hand, calponin was reported to undergo an agonist-induced signal transduction in ferret vascular smooth muscle (16, 20). Recently, Je et al. (9) reported that the contractile response to PE was significantly decreased in the ferret aorta after calponin antisense treatment, suggesting that calponin facilitates alpha -adrenergic contractions in tonic smooth muscle. Nigam et al. (18) reported that the calponin-positive rat aorta was slightly but significantly more sensitive in the contractile response to NE compared with that in the calponin-negative rat aorta. In the present study, we confirmed in the KO mice that the vascular response to PE was reduced to 40-63% of that in the WT mice (Fig. 7).

Together, these results suggest that the impaired contraction/relaxation functions in the vascular smooth muscle itself and/or the reduced alpha -adrenergic contractile response to the sympathetic nervous activity makes MAP unstable in the KO mice and that the enhanced baroreflex sensitivity compensates well for the impairments by increasing HR variability.

We hypothesized that baroreceptor denervation in the KO mice would induce higher fluctuations in MAP than that in the WT mice if the baroreflexes in the KO mice compensate for the MAP fluctuation due to impaired contraction/relaxation functions of the vascular smooth muscle itself. Against our hypotheses, however, there was no higher increase in the fluctuation of MAP for the KO mice than that for the WT mice (Table 1). Moreover, we found the vascular response to PE was reduced (Fig. 7) and that MAP in the KO mice did not increase significantly after denervation despite the possible increase in sympathetic nervous outflow, whereas MAP in the WT mice significantly increased (Table 1). These results suggest that the enhanced baroreflex sensitivity in the KO mice was a compensatory adaptation to the blunted alpha -adrenergic response of the vascular smooth muscles to sympathetic nervous activity elicited by baroreflexes rather than by impaired contraction/relaxation functions of the muscle itself (14, 23).

Matthew et al. (14) reported that the amount of actin was reduced by 25-50% in smooth muscle in the same line of KO mice used in the present study. The possibility may not be excluded that the decreased actin filament in the smooth muscle for the KO mice rather than the absence of calponin was responsible for the reduced vascular sensitivity to PE. However, no difference in the response to SNP between the two groups was observed, suggesting that the reduced sensitivity to PE was more associated with alpha -adrenergic signal transduction in the smooth muscle than with decreased actin filament.

As shown in Table 2 and Fig. 8, drug-induced baroreflex sensitivity was not significantly different between the WT and KO mice and not identical to the higher spontaneous baroreflex sensitivity in the KO mice (Table 1). There are no known studies explaining the mechanisms. However, the baroreflex sensitivity may vary in various conditions in free-moving animals by efferent control to the cardiovascular center in the brain stem from the higher central nervous system (21). For example, the baroreflex sensitivity was reported to decrease during exercise (3, 4) and after exercise (5) compared with that before exercise. Recently, Kajeker et al. (10) studied the role of rostral ventrolateral medulla neurons in controlling arterial baroreflex sensitivity and reported that GABA signaling in the brain stem increased after a bout of exercise to decrease arterial baroreflex sensitivity, leading to hypotension. Moreover, microinjection of the NO synthetase inhibitor into this area increased and the NO donor SNP reduced sympathetic outflow, perhaps via an inhibitory effect on sympathoexcitatory neurons in the brain stem (28). These results suggest that the enhanced spontaneous baroreflex sensitivity in the KO mice was caused by central modulation to the cardiovascular center in the brain stem and the enhancement was diminished by the administration of the drugs, as in the present study.

As shown in Table 1, the spontaneous baroreflex sensitivity was one-third and one-half of the drug-induced baroreflex gain in the WT and KO mice, respectively, despite the same amplitude of change in MAP (± ~5 mmHg) from the baseline (Fig. 8 and Table 2). To determine spontaneous baroreflex sensitivity, MAP and HR were analyzed every 4 s, much shorter than the 30 s to determine drug-induced baroreflex sensitivity, a period for HR and/or MAP to return to the baseline after the injections. However, the spontaneous changing rate of MAP was 1-7 mmHg/s, identical to that of drug-induced MAP of 1-8 mmHg/s, suggesting that baroreflex sensitivity in both methods was determined from the HR response similar to the changing rate of MAP. The discrepancy in the baroreflex sensitivity between the two methods may be due to the difference in the regression analyses: a linear regression (spotaneous) and a curvilinear regression (drug induced). In the present study, we found the spontaneous baroreflex sensitivity in the KO mice was twofold higher than that in the WT mice.

The reason for intra-arterial injection of SNP in the present study was because in preliminary experiments in KO mice, HR increased immediately after the intravenous injection of SNP before MAP started to decrease. The precise mechanism for this phenomenon in the KO mice is unclear. However, the high concentration of SNP in circulating blood after a bolus injection into the central vein may modulate baroreflex sensitivity in the brain stem (28) or affect the pacemaker of the heart through direct or indirect effects. Although this immediate response of HR was not observed after intravenous injection of PE, the intra-arterial injection of PE was performed to standardize the procedure.

In summary, the vascular alpha -adrenergic response was impaired in the KO mice. Although there was no significant difference in the drug-induced baroreflex sensitivity between the WT and KO mice, the enhance spontaneous baroreflex sensitivity and the higher frequency of negative correlation between MAP and HR in the KO mice suggested that the baroreflex may work as a compensatory adaptation to the impairment of the vascular alpha -adrenergic response. Thus calponin may play an important role in controlling MAP by increasing the vascular alpha -adrenergic response to sympathetic nervous activity.


    APPENDIX
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
APPENDIX
REFERENCES


&Dgr;x<SUB>i</SUB>=x<SUB>i</SUB>−<FR><NU>1</NU><DE>n</DE></FR> <LIM><OP>∑</OP><LL><IT>i=i</IT></LL><UL><IT>i+n−1</IT></UL></LIM><IT>x<SUB>i</SUB></IT>

&Dgr;y<SUB>i</SUB>=y<SUB>i</SUB>−<FR><NU>1</NU><DE>n</DE></FR> <LIM><OP>∑</OP><LL><IT>i=i</IT></LL><UL><IT>i+n−1</IT></UL></LIM><IT>y<SUB>i</SUB></IT>

R(i)=<FENCE> <LIM><OP>∑</OP><LL><IT>i=i</IT></LL><UL><IT>i+n−1</IT></UL></LIM> <IT>&Dgr;X<SUB>i+&Dgr;i</SUB>·&Dgr;y<SUB>i</SUB>− </IT><FR><NU>1</NU><DE><IT>n</IT></DE></FR> <LIM><OP>∑</OP><LL><IT>i=i</IT></LL><UL><IT>i+n</IT></UL></LIM> <IT>&Dgr;X</IT><SUB><IT>i+&Dgr;i</IT></SUB><IT>·</IT><LIM><OP>∑</OP><LL><IT>i=i</IT></LL><UL><IT>i+n</IT></UL></LIM> <IT>&Dgr;y<SUB>i</SUB></IT></FENCE><IT>/</IT>[(<IT>n−</IT>1)<IT>S<SUB>x</SUB> · S<SUB>y</SUB></IT>]
where xi is mean arterial pressure; yi is heart rate; R(i) is the cross-correlation function between xi and yi, and Sx and Sy are the standard deviations of xi and yi, respectively, and where
Sx<SUP>2</SUP>=<FENCE><LIM><OP>∑</OP><LL><IT>i=i</IT></LL><UL><IT>i+n</IT></UL></LIM> <IT>&Dgr;x</IT><SUP>2</SUP><SUB><IT>i+&Dgr;i</IT></SUB><IT>−n</IT>(<OVL><IT>&Dgr;x</IT></OVL>)<SUP>2</SUP></FENCE><IT>/</IT>(<IT>n−</IT>1)

Sy<SUP>2</SUP>=<FENCE><LIM><OP>∑</OP><LL><IT>i=i</IT></LL><UL><IT>i+n</IT></UL></LIM> <IT>&Dgr;y</IT><SUP>2</SUP><SUB><IT>i</IT></SUB><IT>−n</IT>(<OVL><IT>&Dgr;y</IT></OVL>)<SUP>2</SUP></FENCE><IT>/</IT>(<IT>n−</IT>1)

<OVL>&Dgr;x</OVL>=<FR><NU>1</NU><DE>n</DE></FR> <LIM><OP>∑</OP><LL><IT>i=i</IT></LL><UL><IT>n</IT></UL></LIM><IT> &Dgr;x<SUB>i+&Dgr;r</SUB>, <OVL>&Dgr;y</OVL> = </IT><FR><NU>1</NU><DE><IT>n</IT></DE></FR> <LIM><OP>∑</OP><LL><IT>i=i</IT></LL><UL><IT>n</IT></UL></LIM> &Dgr;y<SUB>i</SUB>
where Sx2 and Sy2 are the standard variances of xi and yi, respectively, i is the data number during the resting period (i = 0, 1, 2, ...), Delta i is the lag number for 0.6 s (= 6), and n is the data number every 4 s to calculate R(i) (= 40).


    ACKNOWLEDGEMENTS

The authors thank J. Itoh for technical assistance in developing a computer program to collect data. We also thank the staff of the Department of Sports Medicine, Shinshu University School of Medicine for helpful comments and invaluable discussions on this study.


    FOOTNOTES

This work was supported in part by grants from the Ministry of Education, Science, Sports, and Culture of Japan and also supported by Ground-based Research Announcement for Space Utilization from the Japan Space Forum.

Address for reprint requests and other correspondence: H. Nose, Dept. of Sports Medicine, Shinshu Univ. School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan (E-mail: nosehir{at}sch.md.shinshu-u.ac.jp).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

First published November 14, 2002;10.1152/ajpheart.00610.2002

Received 16 July 2002; accepted in final form 12 November 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
APPENDIX
REFERENCES

1.   Basar, E, and Weiss C. Vasculature and Circulation: The Role of Myogenic Reactivity in the Regulation of Blood Flow. Amsterdam: Elsevier/North-Holland, 1981, p. 39-62.

2.   Bertinieri, G, Di Rienzo M, Cavallazzi A, Ferrari AU, Pedotti A, and Mancia G. Evaluation of baroreceptor reflex by blood pressure monitoring in unanesthetized cats. Am J Physiol Heart Circ Physiol 254: H377-H383, 1988[Abstract/Free Full Text].

3.   Bristow, JD, Brown EB, Jr, Cunningham DJC, Howson MG, Strange Petersen E, Pickering TG, and Sleight P. Effect of bicycling on the baroreflex regulation of pulse interval. Circ Res 28: 582-592, 1971[ISI].

4.   Burger, HR, Chandler MP, Rodenbaugh DW, and DiCarlo SE. Dynamic exercise shifts the operating point and reduces the gain of the arterial baroreflex in rats. Am J Physiol Regulatory Integrative Comp Physiol 275: R2043-R2048, 1998[Abstract/Free Full Text].

5.   Halliwill, JR. Mechanisms and clinical implications of post-exercise hypotension in humans. Exerc Sport Sci Rev 29: 65-70, 2001[Medline].

6.   Iellamo, F, Legramante JM, Raimondi G, and Peruzzi G. Baroreflex control of sinus node during dynamic exercise in humans: effects of central command and muscle reflexes. Am J Physiol Heart Circ Physiol 272: H1157-H1164, 1997[Abstract/Free Full Text].

7.   Iellamo, F, Pizzinelli P, Massaro M, Raimondi G, Peruzzi G, and Legramante JM. Muscle metaboreflex contribution to sinus node regulation during static exercise: insights from spectral analysis of heart rate variability. Circulation 100: 27-32, 1999[Abstract/Free Full Text].

8.   Jaworowski, Å, Anderson KI, Arner A, Engström M, Gimona M, Strasser P, and Small JV. Calponin reduces shortening velocity in skinned taenia coli smooth muscle fibres. FEBS Lett 365: 167-171, 1995[ISI][Medline].

9.   Je, HD, Gangopadhyay SS, Ashworth TD, and Morgan KG. Calponin is required for agonist-induced signal transduction-evidence from an antisense approach in ferret smooth muscle. J Physiol (Lond) 537: 567-577, 2001[Abstract/Free Full Text].

10.   Kajekar, R, Chen CY, Mutoh T, and Bonham AC. GABAA receptor activation at medullary sympathetic neurons contributes to postexercise hypotension. Am J Physiol Heart Circ Physiol 282: H1615-H1624, 2002[Abstract/Free Full Text].

11.   Kent, BB, Drane JW, Blumenstein B, and Manning JW. A mathematical model to assess changes in the baroreceptor reflex. Cardiology 57: 295-310, 1972[ISI][Medline].

12.   Kreiger, EM. Neurogenic hypertension in the rat. Circ Res 15: 511-521, 1964[Abstract/Free Full Text].

13.   Madeddu, P, Salis MB, and Emanueli C. Altered baroreflex control of heart rate in bradykinin B2-receptor knockout mice. Immunopharmacology 45: 21-27, 1999[ISI][Medline].

14.   Matthew, JD, Khromov AS, McDuffie MJ, Somlyo AV, Somlyo AP, Taniguchi S, and Takahashi K. Contractile properties and proteins of smooth muscles of a calponin knockout mouse. J Physiol (Lond) 529: 811-824, 2000[Abstract/Free Full Text].

15.   Mattson, DL. Long-term measurement of arterial blood pressure in conscious mice. Am J Physiol Regulatory Integrative Comp Physiol 274: R564-R570, 1998[Abstract/Free Full Text].

16.   Menice, CB, Hulvershorn J, Adam LP, Wang CA, and Morgan KG. Calponin and mitogen-activated protein kinase signaling in differentiated vascular smooth muscle. J Biol Chem 272: 25157-25161, 1997[Abstract/Free Full Text].

17.   Merrill, DC, Thompson MW, Carney CL, Granwehr BP, Schlager G, Robillard JE, and Sigmund CD. Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest 97: 1047-1055, 1996[ISI][Medline].

18.   Nigam, R, Triggle CR, and Jin JP. H1- and h2-calponins are not essential for norepinephrine- or sodium fluoride-induced contraction of rat aortic smooth muscle. J Muscle Res Cell Motil 19: 695-703, 1998[ISI][Medline].

19.   Obara, K, Szymanski PT, Tao T, and Paul RJ. Effects of calponin on isometric force and shortening velocity in permeabilized taenia coli smooth muscle. Am J Physiol Cell Physiol 270: C481-C487, 1996[Abstract/Free Full Text].

20.   Parker, CA, Takahashi K, Tao T, and Morgan KG. Agonist-induced redistribution of calponin in contractile vascular smooth muscle cells. Am J Physiol Cell Physiol 267: C1262-C1270, 1994[Abstract/Free Full Text].

21.   Rowell, LB, O'Leary DS, and Kellogg DL, Jr. Integration of cardiovascular control systems in dynamic exercise. In: Handbook of Physiology. Exercise, Regulation, and Integration of Multiple Systems. Bethesda, MD: Am. Physiol. Soc, 1996, sect. 12, chapt. 17, p. 770-838.

22.   Takahashi, K, Hiwada K, and Kokubu T. Vascular smooth muscle calponin. A novel troponin T-like protein. Hypertension 11: 620-626, 1988[Abstract/Free Full Text].

23.   Takahashi, K, Yoshimoto R, Fuchibe K, Fujishige A, Mitsui-Saito M, Hori M, Ozaki H, Yamamura H, Awata N, Taniguchi S, Katsuki M, Tsuchiya T, and Karaki H. Regulation of shortening velocity by calponin in intact contracting smooth muscles. Biochem Biophys Res Commun 279: 150-157, 2000[ISI][Medline].

24.   Van Vliet, BN, Chafe LL, and Montani JP. Contribution of baroreceptors and chemoreceptors to ventricular hypertrophy produced by sino-aortic denervation in rats. J Physiol (Lond) 516: 885-895, 1999[Abstract/Free Full Text].

25.   Walther, T, Wessel N, Kang N, Sander A, Tschöpe C, Malberg H, Bader M, and Voss A. Altered heart rate and blood pressure variability in mice lacking the Mas protooncogene. Braz J Med Biol Res 33: 1-9, 2000[ISI][Medline].

26.   Winder, SJ, and Walsh MP. Smooth muscle calponin. Inhibition of actomyosin MgATPase and regulation by phosphorylation. J Biol Chem 265: 10148-10155, 1990[Abstract/Free Full Text].

27.   Yoshikawa, H, Taniguchi SI, Yamamura H, Mori S, Sugimoto M, Miyado K, Nakamura K, Nakao K, Katsuki M, Shibata N, and Takahashi K. Mice lacking smooth muscle calponin display increased bone formation that is associated with enhancement of bone morphogenetic protein responses. Genes Cells 3: 685-695, 1998[Abstract].

28.   Zanzinger, J. Role of nitric oxide in the neural control of cardiovascular function. Cardiovasc Res 43: 639-649, 1999[Abstract/Free Full Text].


Am J Physiol Heart Circ Physiol 284(3):H939-H946
0363-6135/03 $5.00 Copyright © 2003 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. Laude, V. Baudrie, and J.-L. Elghozi
Applicability of recent methods used to estimate spontaneous baroreflex sensitivity to resting mice
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R142 - R150.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. Masuki, J. H. Eisenach, F. A. Dinenno, and M. J. Joyner
Reduced forearm {alpha}1-adrenergic vasoconstriction is associated with enhanced heart rate fluctuations in humans
J Appl Physiol, March 1, 2006; 100(3): 792 - 799.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/3/H939    most recent
00610.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masuki, S.
Right arrow Articles by Nose, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masuki, S.
Right arrow Articles by Nose, H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online